Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Matthew M, Ippolito"'
Autor:
Jean-Bertin Bukasa Kabuya, Matthew M. Ippolito, Jay Sikalima, Clifford Tende, Davies Champo, David Mwakazanga, Anna Marie P. Young, Modest Mulenga, Gershom Chongwe, Christine Manyando
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended by the World Health Organization for the prevention of malaria in pregnancy (MIP)-associated adverse outcomes in high burden
Externí odkaz:
https://doaj.org/article/af8458ce4d9f458eaa370cda25b379b2
Autor:
Kathryn D. Jackson, Colleen R. Higgins, Sarah K. Laing, Chiluba Mwila, Tamaki Kobayashi, Matthew M. Ippolito, Sean Sylvia, Sachiko Ozawa
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Many countries are striving to become malaria-free, but global reduction in case estimates has stagnated in recent years. Substandard and falsified medicines may contribute to this lack of progress. Zambia aims to eliminate their
Externí odkaz:
https://doaj.org/article/446f120e62da4651a2c6a09f8f5da6bc
Autor:
Jean-Bertin Bukasa Kabuya, Arthur Mataka, Gerald Chongo, Luc Kambale Kamavu, Priscilla N’gandu Chola, Christine Manyando, Vincent De Brouwere, Matthew M. Ippolito
Publikováno v:
International Journal for Equity in Health, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background Maternal mortality in sub-Saharan Africa remains high despite programmatic efforts to improve maternal health. In 2007, the Zambian Ministry of Health mandated facility-based maternal death review (MDR) programs in line with World
Externí odkaz:
https://doaj.org/article/a95be81f897a4410bca22e055067bcad
Autor:
Rahul P. Bakshi, Lee M. Tatham, Alison C. Savage, Abhai K. Tripathi, Godfree Mlambo, Matthew M. Ippolito, Elizabeth Nenortas, Steve P. Rannard, Andrew Owen, Theresa A. Shapiro
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-8 (2018)
Long-acting antimalarials could provide improved prophylaxis and treatment options in the field. Here, Bakshi et al. develop a long-acting injectable atovaquone nanomedicine that prevents malaria infection prophylactically for up to 4 weeks in mice w
Externí odkaz:
https://doaj.org/article/e2bbca833b9043c393d3ffbbdc23b805
Autor:
Matthew M. Ippolito, Jean-Bertin Kabuya, Manuela Hauser, Benjamin Kussin-Shoptaw, Austin Peer, Marco Ruegg, Albert Baschong, Thomas Louis, William Moss
Publikováno v:
Journal of Clinical and Translational Science, Vol 4, Pp 40-40 (2020)
OBJECTIVES/GOALS: Severe malarial anemia due to Plasmodium falciparum is often accompanied by thrombocytopenia. Treatment includes transfusion of whole blood, which contains erythrocytes, platelets, and other blood components. The objective of the st
Externí odkaz:
https://doaj.org/article/c3aa043e4403472591f86c2c7c771804
Autor:
Clark H. Cunningham, Jean-Bertin Bukasa Kabuya, Kara A. Moser, Jonathan J. Juliano, Matthew M. Ippolito
Publikováno v:
Current Epidemiology Reports
Purpose of Review Five years have passed since the World Health Organization released its Global Technical Strategy for Malaria (GTS). In that time, progress against malaria has plateaued. This review focuses on the implications of antimalarial drug
Autor:
Julia C. Pringle, Mwiche Siame, Jonathan J. Juliano, William J. Moss, Steven R. Meshnick, Liusheng Huang, Peter O Oluoch, Matthew M. Ippolito, Philip E. Thuma, Jeffrey A. Bailey, Ozkan Aydemir, Francesca T. Aweeka, Theresa A. Shapiro, Ben Katowa
Publikováno v:
The American journal of tropical medicine and hygiene, vol 103, iss 6
Am J Trop Med Hyg
Am J Trop Med Hyg
Artemether–lumefantrine (AL) is a first-line agent for uncomplicated malaria caused by Plasmodium falciparum. The WHO recommends periodic therapeutic efficacy studies of antimalarial drugs for the detection of malaria parasite drug resistance and t
Autor:
Matthew M. Ippolito, Peter R. Mason, Zvifadzo Matsena-Zingoni, Tamaki Kobayashi, Susan L Mutambu, Sungano Mharakurwa, Charmaine Matimba, Shungu Munyati, Nobert Mudare, Gladys Maponga, Tanatswa Xuxa Gara, Nicholas Midzi, William J. Moss, Lovemore Gwanzura, Aramu Makuwaza
Publikováno v:
J Infect Dis
Removal of chloroquine from national malaria formularies can lead to the reversion of resistant Plasmodium falciparum to wild-type. We report a steep decline in chloroquine-resistant P falciparum within 10 years of national discontinuation of chloroq
Autor:
Manuela Hauser, Jean-Bertin B Kabuya, Molly Mantus, Luc K Kamavu, James L Sichivula, Wycliffe M Matende, Nora Fritschi, Timothy Shields, Frank Curriero, Anton Kvit, Gershom Chongwe, William J Moss, Nicole Ritz, Matthew M Ippolito
Publikováno v:
Clin Infect Dis
Background Malaria is a leading cause of morbidity and mortality in refugee children in high-transmission parts of Africa. Characterizing the clinical features of malaria in refugees can inform approaches to reduce its burden. Methods The study was c
Autor:
Matthew M, Ippolito, Jean-Bertin B, Kabuya, Manuela, Hauser, Luc K, Kamavu, Proscovia Miiye, Banda, Lisa R, Yanek, Rubab, Malik, Modest, Mulenga, Jeffrey A, Bailey, Gershom, Chongwe, Thomas A, Louis, Theresa A, Shapiro, William J, Moss
Publikováno v:
Clin Infect Dis
BACKGROUND: Severe malaria resulting from Plasmodium falciparum infection is the leading parasitic cause of death in children worldwide, and severe malarial anemia (SMA) is the most common clinical presentation. The evidence in support of current blo